Litigation Details for Biogen Inc. v. Sandoz Inc. (D. Del. 2022)
✉ Email this page to a colleague
Biogen Inc. v. Sandoz Inc. (D. Del. 2022)
| Docket | ⤷ Try a Trial | Date Filed | 2022-09-09 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory B. Williams |
| Jury Demand | None | Referred To | |
| Parties | SANDOZ INTERNATIONAL GMBH | ||
| Patents | 10,046,000; 10,119,976; 10,233,245; 6,509,376; 6,602,503; 7,320,999; 7,619,001; 7,803,840; 8,124,350; 8,399,514; 8,871,449; 9,022,022; 9,024,034; 9,035,031; 9,035,033; 9,493,567; 9,709,575 | ||
| Attorneys | Theresa Tan | ||
| Firms | Morris, Nichols, Arsht & Tunnell; Young, Conaway, Stargatt & Taylor LLP | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Biogen Inc. v. Sandoz Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Biologic Drugs cited in Biogen Inc. v. Sandoz Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Biogen Inc. v. Sandoz Inc. (D. Del. 2022)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2022-09-19 | 10 | Redacted Document | the ’845 patent is attached as Exhibit 3. U.S. Patent No. U.S. 10,119,976 118… 118. U.S. Patent No. 10,119,976 (“the ’976 patent”), entitled “Method of Assessing Risk of PML,”…and Declaration of Infringement of U.S. Patent No. 10,119,976) 217. Biogen re-alleges and…Page 2 of 107 PageID #: 1325 9,790,533; U.S. 10,119,976; U.S. 10,233,245; U.S. 10,308,706; U.S. 10,444,234…covered by US Patent claims and corresponding patent claims outside the US. The foregoing patent claims are | External link to document |
| 2023-02-23 | 136 | Redacted Document | 2 MS. WANG: Objection. 10:46:00 10 MS. WANG: Objection. 10:43… to various patents and patent applications. U.S. patents, as well as most foreign patents, are generally… U.S. Patent No. 9,096,879, U.S. Patent No. 10,844,416, U.S. Patent No. 9,316,641, U.S. Patent No. 10,119,976…entitled to additional patent term pursuant to the patent term adjustment or patent term extension provisions…“PI Patents” means the patents identified in Plaintiffs’ Notice of Initial Selection of Patent Claims | External link to document |
| 2022-12-08 | 56 | Redacted Document | the ’845 patent is attached as Exhibit 3. U.S. Patent No. U.S. 10,119,976 110… 110. U.S. Patent No. 10,119,976 (“the ’976 patent”), entitled “Method of Assessing Risk of PML,”… (Declaration of Infringement of U.S. Patent No. 10,119,976) 191. Biogen re-alleges and…,567; U.S. 10,233,245; U.S. 11,292,845; U.S. 10,119,976; U.S. 10,677,803; U.S. 11,280,794; U.S. 9,316,641…covered by US Patent claims and corresponding patent claims outside the US. The foregoing patent claims are | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
